Cancer drugs

Tel Aviv University study reveals how tumors hijack immune cells to fuel cancer growth and spread

The research focused on macrophages, immune cells responsible for removing damaged and dead cells from the body.

|ByTHE MEDIA LINE STAFF
Radiation therapy for a cancer patient
Medicine cabinet

Israeli-founded AI biotech Immunai launches drug-discovery collaboration with Boehringer Ingelheim

The collaboration will use Immunai’s single-cell AI platform to identify T-cell targets in cancer and autoimmune diseases.

|ByJERUSALEM POST STAFF
Cancer Cell Spread and oncology or Malignant Cancerous Growth and Metastasis anatomy concept as growing tumor cells and Malignancy disease spreading metastasized as a 3D illustration.

New shot for cancer can eradicate whole tumors in patients, trial shows - report

Of the 102 participants, 43 saw a difference in the size of their tumors: some 28 saw their tumors shrink significantly, while 15 of the patients’ tumors dissolved altogether.

|ByJERUSALEM POST STAFF
Breakthrough in the treatment of pancreatic cancer

Late-stage trial finds a new pill extends survival for people with pancreatic cancer

The success of the Phase 3 study reverberated beyond the clinic, sending the company’s shares up more than a third in a single day.

|ByJERUSALEM POST STAFF

Israeli company wins license to develop plant-based cancer treatment

The company recently reported that one of its products assisted in killing breast cancer cells by up to six times the amount of current treatments.

JANUARY 3, 2022ByJERUSALEM POST STAFF
Dividing cancer cell

Israeli research institute makes great contributions to cancer research

Technologies including artificial intelligence-based diagnostic software may be changing how the disease is detected and treated in the future.

DECEMBER 17, 2021ByJERUSALEM POST STAFF
Technion–Israel Institute of Technology

Weizmann study identifies genes connected to myeloma drug resistance

The Weizmann team found that they could silence one of the genes responsible for drug resistance to help make drugs more effective.

FEBRUARY 28, 2021ByJERUSALEM POST STAFF
Resistant multiple myeloma cells (violet-blue) in two samples, seen under a microscope

Canadian fund for Israel cancer research announced $1 million donation

"This extraordinary gift will make a real difference in the fight against female reproductive cancers," assured Bryna Goldberg, ICRF's international chairwoman.

NOVEMBER 5, 2020BySARAH BEN-NUN
Cancer illustrative

Tamir Gilat turns a death sentence into a life with meaning

“I was living from holiday to holiday – from Hanukkah to Passover, from Passover to Shavuot."

NOVEMBER 5, 2020ByALAN ROSENBAUM
TAMIR GILAT: Goals, Giving and Gratitude.

Calm, comfortable cancer treatment at Place2Heal

Place2Heal is transforming Israel’s outpatient cancer treatment centers into less stressful, even tranquil spaces

NOVEMBER 4, 2020ByABIGAIL KLEIN LEICHMAN

FDA gives Jerusalem-based company go-ahead to start cancer drug trials

The drug, DSP107 works by both boosting the body's natural immune system, and breaking down the defenses of the cancer cells.

AUGUST 12, 2020ByDONNA RACHEL EDMUNDS
Cancer cells [illustrative]

Could a study of sea urchins help scientists develop new cancer drugs?

The team showed that the sea urchin’s anatomy is not only physically but genetically analogous to humans’ anatomy.

JULY 5, 2019BySONIA EPSTEIN
Sea Urchin